Welcome to our dedicated page for Avantis US Small Cap Value ETF news (Ticker: AVUV), a resource for investors and traders seeking the latest updates and insights on Avantis US Small Cap Value ETF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Avantis US Small Cap Value ETF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Avantis US Small Cap Value ETF's position in the market.
Avantis Investors (AVEM), a global investment offering from American Century Investments, reported surpassing $150 billion in assets under management. This follows crossing $100 billion in December 2025, achieved in just over six and a half years since its first strategy launched in September 2019.
Flagship ETFs AVUV and AVEM each now exceed $25 billion in assets. Growth is supported by a 2025 strategic alliance with CIBC Asset Management to launch eight Avantis CIBC ETFs in Canada and a February 2026 expansion of its European UCITS ETF lineup.